Effects of furosemide on pulmonary arterial pressures of normal horses and horses affected with chronic obstructive pulmonary disease (COPD).

The research focuses on examining the influence of the diuretic furosemide on the pulmonary arterial pressures (PAP) of healthy horses and horses suffering from Chronic Obstructive Pulmonary Disease (COPD), a condition that is related to instances of pulmonary haemorrhage.

Introduction and Background

• The study asserts that pulmonary haemorrhage is a common issue in racehorses. However, the root causes and mechanics remain unknown due to the lack of pathological studies conducted shortly after an instance of pulmonary haemorrhage. The paper also states that it is uncertain if the haemorrhage stems from pulmonary arterioles or venules.
• The research also points out that a majority of horses suffering from pulmonary haemorrhage in Britain exhibit symptoms of Chronic Obstructive Pulmonary Disease (COPD). These horses with COPD tend to have increased pulmonary arterial pressure (PAP) which amplifies with exercise; hence, horses with COPD may be more prone to pulmonary haemorrhage.
• The paper mentions that furosemide, a diuretic, is popularly used as a preventative treatment for pulmonary haemorrhage in the United States. The effect of the drug on blood flow, secondary to its capacity to reduce plasma volume, could explain its perceived prevention of pulmonary haemorrhage.

Methodology

• The study was conducted on 20 horses of various breeds, some of which did not showcase any signs of respiratory diseases and served as control, while others diagnosed with COPD were in the remission phase.
• The pulmonary arterial trunk in these horses was catheterised and the pressure recorded. Following the resting mean PAP value recording, the horses were administered with furosemide and observed for variations in PAP.
• The COPD afflicted horses were separated into two groups. For one group and the control group, their PAP was continually monitored for 30 minutes post furosemide administration, while the other group was observed over a longer period of 2 hours and 30 minutes.

Results

• The COPD affected horses in one group exhibited lower PAP levels suggesting greater COPD remission. After administering furosemide, no significant changes in PAP were noted in any of the groups.
• Nevertheless, a slight but not statistically significant decrease in PAP was observed in the control group 12 minutes after furosemide administration while a small increase, also not statistically significant, was seen in the COPD affected animals after furosemide administration.

Discussion

• The small and transient decrease in PAP in the control animals after furosemide administration is noted, suggesting more detailed research is required to confirm the efficacy and impact of furosemide on PAP.